Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384864 · ClinicalTrials.gov registry record · Early Phase 1
Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia
A Early Phase 1 study of Barrett's Esophagus and Intraepithelial Neoplasia, sponsored by Anandasabapathy, Sharmila, M.D..
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01384864: Completed Early Phase 1 study of Barrett's Esophagus and Intraepithelial Neoplasia, sponsored by Anandasabapathy, Sharmila, M.D..
NCT01384864 is a Early Phase 1 study of Barrett's Esophagus and Intraepithelial Neoplasia that has completed, run by Anandasabapathy, Sharmila, M.D.. The registered enrollment target is 30 participants, below the 523-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01384864, a Early Phase 1 study of Barrett's Esophagus and Intraepithelial Neoplasia, has completed, sponsored by Anandasabapathy, Sharmila, M.D..
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this pilot study is to determine whether multispectral imaging increases the diagnostic accuracy of the current standard of high-definition white-light endoscopy for the detection of Barrett's-associated neoplasia (high grade dysplasia or cancer). The investigators goal is to develop a multispectral endoscopic platform that can be used to survey a large surface area and, potentially, serve as a 'red flag' for microendoscopic imaging of small areas. The goal of this pilot study is to preliminarily determine the accuracy of these modalities during the endoscopic surveillance of Barrett's esophagus.
Conditions Studied
Interventions
- DRUG proflavine
Study Locations (1)
New York
- Mount Sinai School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-12 |
| Phase | Early Phase 1 |
What the finished NCT01384864 record still lists
NCT01384864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 523-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which proflavine is the first listed.
NCT01384864 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01384864 about?
NCT01384864 is a clinical study titled "Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia". The overall objective of this pilot study is to determine whether multispectral imaging increases the diagnostic accuracy of the current standard of high-definition white-light endoscopy for the detection of Barrett's-associated neoplasia (high grade dysplasia or cancer). The investigators goal is t...
What is the current status of trial NCT01384864?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2011-08. Estimated completion is 2015-12.
What conditions does trial NCT01384864 study?
This clinical trial studies the following conditions: Barrett's Esophagus, Intraepithelial Neoplasia.
What interventions are being tested in trial NCT01384864?
The interventions under investigation include: proflavine (DRUG).
Who is sponsoring clinical trial NCT01384864?
This trial is sponsored by Anandasabapathy, Sharmila, M.D., which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01384864 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01384864's enrollment target sits among peer trials
30 19th of 22 higher than 4 of 22 other Barrett's Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett's Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Barrett's Esophagus Related Neoplasia (BERN) Project
RECRUITING
-
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING
-
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
RECRUITING
-
Navicam for Detection of Barrett's Esophagus
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia